CONFERENCE COMMITTEE REP. NO. 4

Honolulu, Hawaii

                 , 2017

RE:    S.B. No. 514

       S.D. 1

       H.D. 1

       C.D. 1

Honorable Ronald D. Kouchi

President of the Senate

Twenty-Ninth State Legislature

Regular Session of 2017

State of Hawaii

Honorable Joseph M. Souki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2017

State of Hawaii

Sirs:

     Your Committee on Conference on the disagreeing vote of the Senate to the amendments proposed by the House of Representatives in S.B. No. 514, S.D. 1, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO HEALTH,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

     The purpose of this measure is to:

     (1)  Authorize pharmacists to administer the human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines to persons between eleven and seventeen years of age; and

     (2)  Specify the requirements pharmacists must meet prior to administering the human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines.

     Your Committee on Conference finds that the human papillomavirus is a very common virus, which is associated with multiple cancers, including anogenital cancer, oropharyngeal cancer, and genital warts.  The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists recommend routine vaccination with the human papillomavirus vaccine for preteen boys and girls so they are protected prior to any exposure to the virus.  However, recent data released by the Centers for Disease Control and Prevention shows that human papillomavirus vaccination rates trail behind other teen vaccines, in part because the two-part vaccination requires a booster to complete the vaccination series.  Your Committee on Conference further finds that in addition to the human papillomavirus vaccine, three other vaccines, including the Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines, make up what is known as the "Adolescent Platform", a series of shots recommended for adolescents between the ages of eleven and twelve.

     This measure enables pharmacists to administer the human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines to persons between eleven and seventeen years of age, which will expand access to these important vaccines and help reduce the incidence of infectious disease, including human papillomavirus and its associated risk of cancers.

     Your Committee on Conference has amended this measure by changing its effective date to upon approval.

     As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of S.B. No. 514, S.D. 1, H.D. 1, as amended herein, and recommends that it pass Final Reading in the form attached hereto as S.B. No. 514, S.D. 1, H.D. 1, C.D. 1.

Respectfully submitted on behalf of the managers:

ON THE PART OF THE HOUSE

ON THE PART OF THE SENATE

____________________________ DELLA AU BELATTI Co-Chair	____________________________ ROSALYN H. BAKER Chair
____________________________ ROY M. TAKUMI Co-Chair